TENAX THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
TENAX THERAPEUTICS, INC. (TENX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $1.37 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $1.37M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $0.00.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2025-12-31 | $1.37M 10-K · filed 2026-03-10 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |